E R Squibb and Sons LLC
Records under this name other than the patents E R Squibb and Sons LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 9 patents it holds.
Back to E R Squibb and Sons LLC
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,072,090 | Human Anti-B7RP1 Neutralizing Antibodies now held by Amgen Inc. In force · High confidence | In force | High confidence | |
| US 11,292,814 | Cation Exchange Chromatography Methods now held by Bristol-Myers Squibb Company In force · Medium confidence | In force | Medium confidence | |
| US 7,611,702 | Tnf-Alpha Blocker Treatment for Enterocolitis Associated with Immunostimulatory Therapeutic Antibody Therapy Term ended Term ended Nov 8, 2026 · High confidence | Term ended | Term ended Nov 8, 2026 | High confidence |
| US 9,387,247 | Monoclonal Antibodies to Programmed Death 1 (PD-1) Term ended Term ended Oct 24, 2026 · High confidence | Term ended | Term ended Oct 24, 2026 | High confidence |
| US 9,492,539 | Monoclonal Antibodies to Programmed Death 1 (PD-1) Term ended Term ended Oct 24, 2026 · High confidence | Term ended | Term ended Oct 24, 2026 | High confidence |
| US 7,625,559 | Antibodies Against Clostridium Difficile Toxins and Uses Thereof Term ended Term ended Oct 20, 2026 · High confidence | Term ended | Term ended Oct 20, 2026 | High confidence |
| US 9,266,945 | Human Anti-B7RP1 Neutralizing Antibodies Term ended Ended no later than Jul 18, 2026 · Medium confidence | Term ended | Ended no later than Jul 18, 2026 | Medium confidence |
| US 9,084,776 | Methods for Treating Cancer Using ANTI-PD-1 Antibodies Term ended Term ended May 2, 2026 · High confidence | Term ended | Term ended May 2, 2026 | High confidence |
| US 9,358,289 | Methods for Treating Cancer Using ANTI-PD-1 Antibodies in Combination with ANTI-CTLA-4 Antibodies Term ended Term ended May 2, 2026 · High confidence | Term ended | Term ended May 2, 2026 | High confidence |
| US 9,492,540 | Methods for Treating Cancer Using ANTI-PD-1 Antibodies Term ended Term ended May 2, 2026 · High confidence | Term ended | Term ended May 2, 2026 | High confidence |